Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 4,118

Document Document Title
WO/2020/095017A1
Molecular complexes comprising 3,6-dichloro-2-methoxybenzoic acid (dicamba) and a compound selected from the group of triazine herbicides are described, together with compositions comprising such molecular complexes, and methods of their...  
WO/2020/084427A1
A system and a method for extracting one or more active compounds from a cannabis biomass are disclosed. The method comprises obtaining a raw biomass of cannabis plant. A prepared biomass may be obtained from the raw biomass and may be m...  
WO/2020/074964A1
The present disclosure relates to compounds of the general formula (I): wherein R1, R2, R3, R4, R5, R6, and R7 may be chosen from different substituents; n is 0, 1, or 2; and X is a hydroxymethyl or a carboxylic acid or a derivative ther...  
WO/2020/044119A3
Described herein are cannabinoid formulations in combination with lavender and/or a lavender extract for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need the...  
WO/2020/050368A1
The purpose of the present invention is to provide: a method for preparing a Vilsmeier reagent, that can be carried out safely, easily, and at a low cost; and a method for producing an aromatic aldehyde or an aromatic ketone, a carboxyli...  
WO/2020/044121A1
Described herein are cannabinoid formulations in combination with phenylalanine for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufacturin...  
WO/2020/044123A1
Described herein are cannabinoid formulations in combination with Boswellia extract for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufact...  
WO/2020/044116A1
Described herein are cannabinoid formulations in combination with curcumin for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufacturing ora...  
WO/2020/044118A1
Described herein are cannabinoid formulations for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof.  
WO/2020/038238A1
Provided is a nicotine eutectic crystal, which is obtained by self-assembling nicotine and 2,6-dihydroxybenzoic acid in a molar ratio of 1 : 1 to 1 : 5 and has a melting point of 159ºC-163ºC. Further provided are a preparation method f...  
WO/2020/028992A1
The invention relates to methods of producing extracts from cannabis plant material, where the extracts comprise cannabinoids and terpenes. The methods comprise extracting fresh or dried plant material with a cold organic solvent. The me...  
WO/2020/022441A1
The present invention addresses the problem of providing an antiviral composition that shows a high solubility of an antiviral component and has an excellent antiviral activity. The present invention further addresses the problem of prov...  
WO/2020/014776A1
An oral dispersible film composition comprising at least one active ingredient and a film forming agent, as well as a method of manufacture of same. The oral dispersible film composition can be free of gum resin, and can be utilized to a...  
WO/2019/242765A1
The present invention provides a compound represented by the formula (I) or an optical isomer thereof, and a tautomer, a pharmaceutically acceptable salt, a prodrug, a hydrate, or a solvate. The various deuterated compounds and salts and...  
WO/2019/217536A9
Compositions that include a bupivacaine salt are provided. The compositions may include bupivacaine linoleate, bupivacaine linolenate or bupivacaine laurate, at least one thermosensitive polymer, and at least one mucoadhesive or dermoadh...  
WO/2019/227202A1
Disclosed are pharmaceutical salts and co-crystals of pentoxifylline, clonidine and linsidomine with caffeic acid, protocatechuic acid or α-lipoic acid, and method for preparing thereof. Also disclosed are topical compositions comprisin...  
WO/2019/223186A1
The invention relates to the technical field of co-crystal pesticides, and in particular relates to a triazole sulcotrione-salicylic acid co-crystal, a preparation method thereof, and an application thereof. The triazole sulcotrione-sali...  
WO/2019/186284A3
This invention relates to novel products of compressed Cannabis flower for medicinal and/or recreational use, and for methods of making such products.  
WO/2019/217536A1
Compositions that include a bupivacaine salt are provided. The compositions may include bupivacaine linoleate, bupivacaine linolenate or bupivacaine laurate, at least one thermosensitive polymer, and at least one mucoadhesive or dermoadh...  
WO/2019/210401A1
A solvent free method of concentrating naturally occurring 2 - carboxylic acid cannabinoids contained in fresh Cannabis: THCA (Tetrahydrocannabinolic acid), CBDA (Cannabidiolic acid), CBNA (Cannabinol acid), CBGa (Cannabigerol acid), CBC...  
WO/2019/212233A1
The present invention relates to a method for preparing 4,4'-dihydroxy-[1,1'-biphenyl-3,3'-dicarboxylic acid], the method comprising a step for preparing a compound represented by chemical formula 1 by reacting a compound represented by ...  
WO/2019/196379A1
Disclosed is a method for catalyzing selective hydrogenolysis of lignin by a nickel-base material loaded by zirconium phosphate. The method is used for preparing a monophenol chemical substance by means of hydrogenolysis. The method comp...  
WO/2019/190823A1
The application relates to pharmaceutically acceptable salts of [3-(4- {2-butyl-l-[4-(4-chloro-phenoxy)-phenyl]-lH-imidazol-4-yl}-p henoxy) -propyl]-diethylamine (Azeliragon) useful in the treatment of RAGE mediated diseases such as Alzh...  
WO/2019/180505A1
Cannabis pods comprising a defined dose of cannabis and methods for making said pods. This method comprises milling or grinding the cannabis, passing it through a mesh or sieve, determining the desired amount of cannabinoid, and encapsul...  
WO/2019/179346A1
The present invention belongs to the field of medicinal chemistry, relates to novel benzoic acid compounds I and II, and relates to the applications thereof in prevention and treatment or remission of cerebral ischemia or ischemia after ...  
WO/2019/174974A1
The invention relates to a fertilizer composition comprising a) zeolitic imidazolate framework ZIF-8; and b) a fertilizer selected from liquid or solid ammonium-containing inorganic fertilizers, liquid or solid organic fertilizers, and u...  
WO/2019/174977A1
The invention relates to a composition comprising a) zeolitic imidazolate framework ZIF-8; and b) Compounds of formula (I) or a stereoisomer, salt, tautomer or N-oxide thereof, wherein the variables have a meaning as defined in the main ...  
WO/2019/172184A1
Provided is a metal imide complex which has a stable structure and is able to be easily synthesized, while being capable of efficiently oxidizing various substrates. A metal imide complex which contains a metal and an imide that serves a...  
WO/2019/159596A1
Provided is a method for preparing a coupled body represented by general formula (3), the coupled body being obtained by reacting a compound represented by general formula (1) and a compound represented by general formula (2) in the pres...  
WO/2019/157592A1
A process of producing an edible powder containing cannabis including providing a desired quantity of cannabis oil, a cannabis isolate or a cannabis distillate, mixing the cannabis oil, cannabis isolate or cannabis distillate with a solv...  
WO/2019/155899A1
The present invention relates to a method for producing vanillin, which comprises: a step (A) wherein a vanillin solution is obtained by subjecting a solution that contains crude vanillin and an aliphatic dicarboxylic acid dialkyl ester ...  
WO/2019/145552A1
The present specification discloses methods of purifying one or more cannabinoids from a plant material using unique biphasic solvent systems and liquid-liquid chromatography as centrifugation partitioning chromatography (CPC) or counter...  
WO/2019/126618A1
Multivariate metal-organic framework compositions and methods of producing multivariate metal-organic frameworks. The metal-organic framework including at least one light-emitting linker in an amount sufficient for the composition to pro...  
WO/2019/115597A1
Enantiopure terphenyl presenting two ortho-located chiral axes having the following structural formula (I) : their process of synthesis and their use as mono or bidentate ligands for asymmetric organometallic reactions, as organocatalyst...  
WO/2019/114811A1
The present application provides a method for synthesis of Roxadustat. A compound as represented by formula (VIII) is used as a raw material, and is reacted with phenol, a vinyl-containing ether, an acid, hydroxylamine, and then the prod...  
WO/2019/079222A1
Provided here are therapeutically effective pharmaceutical compositions containing one or more TREX2 inhibitors, and more specifically methods of administering TREX2 inhibitors to increase the effectiveness of a chemotherapeutic agent. A...  
WO/2019/056123A1
Pharmaceutical compositions comprising one or more cannabinoids and a pharmaceutically acceptable carrier are disclosed. The compositions are in a form suitable for topical administration, and are useful in the treatment of pain. The can...  
WO/2019/056128A1
Compositions comprising two or more cannabinoids, a terpene, and a flavonoid suitable for use in treating insomnia are disclosed. In preferred embodiments, the cannabinoids are cannabidiol and tetrahydrocannabinol, while the terpenes and...  
WO/2019/056129A2  
WO/2019/051222A1
The present disclosure provides a benzene fused heterocyclic derivative of Formula (I): --̅-̅-̅ is a single or double bond; n is an integer of 0 or 1; A is -CH2-, -CH(OH)-, or - C(O)-; G is C or N; X is -CH2-, O, or -C(O)-; Y is alkyl...  
WO/2019/044773A1
The functional skin preparation for external use according to the present invention comprises, as active ingredient(s), an aromatic polyhydroxycarboxylic acid derived from a plant-origin saccharide and a microorganism and/or a derivative...  
WO/2019/028600A1
Disclosed is a new process for the production of carboxylated phenol derivatives comprising at least a step of carboxylation of a mixture of (i) phenol derivative and (ii) phenolate derivative, wherein the molar ratio of (i) / (ii) is co...  
WO/2019/025540A1
The invention relates to 3-acyl-benzamides of formula (I) as herbicides. In formula (I) X, Y, Z and Rx represent radicals such as alkyl, cycloalkyl and halogen.  
WO/2019/014255A1
This invention relates to a process for preparing an alkylsalicylic acid. The process comprises reacting salicylic acid with an olefin having at least four carbon atoms at a temperature ranging from about 50 °C to about 200 °C in the p...  
WO/2018/228081A1
Discloses is a method for synthesizing 4-hydroxybenzoic acid by using PX as a raw material. PX is dissolved in an organic solvent and undergoes oxidation reaction with an oxidant under the action of an M-MOF catalyst, after the reaction ...  
WO/2018/218357A1
A method of treating cachexia is provided. The method includes administering to a human in need thereof an effective amount of a complement inhibitor. The complement inhibitor may be a dimer of acetyl salicylic acid, including 5,5'-methy...  
WO/2018/209973A1
The present invention provides compounds as represented by structural formula (I), its S-isomers and R-isomers, and its pharmaceutically acceptable salts. In formula (I), R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, and R14 ar...  
WO/2018/205022A1
There is provided an ocular drug delivery formulation comprising a delivery carrier comprising a cellulosic polymer and an anionic polysaccharide and nanoparticles comprising an amphiphilic non-ionizable block copolymer and a cannabinoid...  
WO/2018/177232A1
The present invention provides a complex of formula (I) or a solvate thereof, wherein n is 1 to 4. The present invention also provides a pharmaceutical composition and an application of the pharmaceutical composition in preventing or tre...  
WO/2018/148848A1
A method and cell line for producing phytocannabinoids and phytocannabinoid analogues in yeast. The method applies, and the cell line includes, a yeast cell transformed with a polyketide synthase CDS and a cytosolic prenyltransferase CDS...  

Matches 1 - 50 out of 4,118